Join
Live feed
·
INSIDERFilingvia Quantisnow
Marker Therapeutics Inc. logo

SEC Form 4: Wasserman Frederick Gerald bought $24,098 worth of Common Stock (10,000 units at $2.41), increasing direct ownership by 23% to 52,565 units

ByQuantisnow·Wall Street's wire, on your screen.
MRKR· Marker Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRKR (Marker Therapeutics Inc.) and more on Quantisnow.